Release Date: 02/12/10 15:05 Summary: Market Update and Earnings Guidance Price Sensitive: Yes Download Document 137.51KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%